Indoco Remedies Limited (NSE:INDOCO)
India · Delayed Price · Currency is INR 260.10
+5.85 (2.30%)
Sep 11, 2026, 3:29 PM IST
Indoco Remedies Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 24,278 | 15,138 | 21,484 | 30,296 | 29,972 | 34,745 | |
Market Cap Growth | -4.94% | -29.54% | -29.09% | 1.08% | -13.74% | 31.13% |
Enterprise Value | 34,774 | 24,877 | 29,404 | 34,594 | 32,544 | 37,132 |
Last Close Price | 263.02 | 164.00 | 232.72 | 327.09 | 321.69 | 370.63 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 431.22 | - | - | 30.77 | 21.07 | 22.45 |
Forward PE | 59.95 | 56.43 | 76.48 | 19.78 | 14.54 | 17.78 |
PS Ratio | 1.30 | 0.82 | 1.29 | 1.67 | 1.80 | 2.26 |
PB Ratio | 2.60 | 1.62 | 2.11 | 2.73 | 2.92 | 3.84 |
P/TBV Ratio | 3.29 | 2.05 | 2.59 | 3.29 | 3.32 | 4.28 |
P/FCF Ratio | 54.31 | 33.87 | - | - | - | 71.63 |
P/OCF Ratio | 12.63 | 7.88 | 22.63 | 19.50 | 16.76 | 19.99 |
PEG Ratio | - | 6.26 | 4.75 | 1.10 | 0.40 | 0.44 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.86 | 1.35 | 1.77 | 1.90 | 1.95 | 2.41 |
EV/EBITDA Ratio | 20.78 | 24.18 | 46.00 | 16.29 | 11.97 | 12.38 |
EV/EBIT Ratio | 102.25 | 155.24 | - | 22.56 | 15.00 | 14.81 |
EV/FCF Ratio | 77.80 | 55.66 | - | - | - | 76.55 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.17 | 1.17 | 0.98 | 0.61 | 0.32 | 0.28 |
Debt / EBITDA Ratio | 6.51 | 9.75 | 14.43 | 3.11 | 1.22 | 0.85 |
Debt / FCF Ratio | - | 24.38 | - | - | - | 5.29 |
Net Debt / Equity Ratio | 1.13 | 1.14 | 0.96 | 0.59 | 0.31 | 0.26 |
Net Debt / EBITDA Ratio | 6.32 | 10.34 | 15.35 | 3.06 | 1.18 | 0.80 |
Net Debt / FCF Ratio | - | 23.80 | -3.76 | -2.40 | -11.29 | 4.93 |
Asset Turnover | - | 0.74 | 0.73 | 0.96 | 1.06 | 1.10 |
Inventory Turnover | - | 1.48 | 1.44 | 1.83 | 1.78 | 1.80 |
Quick Ratio | - | 0.51 | 0.48 | 0.72 | 0.87 | 0.74 |
Current Ratio | - | 1.13 | 1.24 | 1.56 | 1.92 | 1.82 |
Return on Equity (ROE) | - | -10.12% | -7.32% | 9.07% | 14.72% | 18.50% |
Return on Assets (ROA) | - | 0.40% | -0.38% | 5.04% | 8.62% | 11.19% |
Return on Invested Capital (ROIC) | 0.67% | 0.80% | -0.74% | 7.05% | 12.84% | 15.12% |
Return on Capital Employed (ROCE) | - | 1.00% | -0.90% | 10.00% | 17.60% | 23.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.23% | -6.29% | -3.43% | 3.25% | 4.75% | 4.46% |
FCF Yield | 1.84% | 2.95% | -12.16% | -8.93% | -0.95% | 1.40% |
Dividend Yield | 0.07% | 0.12% | 0.09% | 0.46% | 0.70% | 0.40% |
Payout Ratio | - | - | - | 21.03% | 14.57% | 8.91% |
Buyback Yield / Dilution | -15.76% | -0.07% | 0.07% | -0.01% | -0.11% | - |
Total Shareholder Return | -15.69% | 0.06% | 0.16% | 0.45% | 0.58% | 0.40% |